Data as of .
AIPI vs BIOY: which paid, and which earned it?
AIPI and BIOY both write options for income.
What they hold in common
By the books each fund has filed, AIPI and BIOY hold 0% of their money in the same securities at the same weight.
| Only in AIPI | Only in BIOY |
|---|---|
| CROWDSTRIKE HOLDINGS, INC. 11.93% | Treasury Bill 100.00% |
| PALANTIR TECHNOLOGIES INC. 8.40% | |
| NVIDIA CORPORATION 8.23% | |
| Astera Labs, Inc 7.20% | |
| DATADOG, INC. 6.65% | |
| MICRON TECHNOLOGY, INC. 4.15% | |
| SUPER MICRO COMPUTER, INC. 3.95% | |
| IONQ Inc 3.62% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026 and May 31, 2026.
Performance, window by window
| Window | Total return | Cash paid | Against the benchmark | |||
|---|---|---|---|---|---|---|
| AIPI | BIOY | AIPI | BIOY | AIPI | BIOY | |
| 3 months | +7.7% | +2.5% | 8.4% | 14.1% | +11.7 pts | −9.0 pts |
| 6 months | +24.6% | not published | 17.8% | not published | −10.8 pts | not published |
| 1 year | +22.2% | not published | 31.3% | not published | −9.4 pts | not published |
| Since launch | +56.1% | +2.0% | 64.2% | 20.6% | −35.1 pts | −15.3 pts |
| AIPI REX AI EQUITY PREMIUM INCOME ETF Covered call on AIQ, paying weekly | BIOY GraniteShares YieldBOOST Biotech ETF Synthetic covered call on XBI, paying weekly | |
|---|---|---|
| Issuer | REX | GraniteShares |
| Strategy | covered call | synthetic covered call |
| Benchmark | AI and technology (AIQ), used as the AI proxy | Biotech (XBI), used as the proxy |
| Pays | weekly | weekly |
| Payout rate, annualized | 34.4% | 60.0% |
| Expense ratio | 0.65% | 1.07% |
| Cash paid, 1 year | 31.3% | 20.6% (since launch on May 5, 2026) |
| Price change, 1 year | −13.8% | −19.0% |
| Total return, 1 year | +22.2% | +2.0% (since launch on May 5, 2026) |
| Benchmark return, 1 year | +31.6% | +17.3% |
| Ahead or behind | −9.4 pts | −15.3 pts |
| Return of capital, latest estimate | 100% | 96% |
| Age | 836 days | 136 days |
| Net assets | $466m | $1m |
AIPI in plain words
Over the year to Sep 18, 2026, AIPI paid 31.3% of its starting value in cash distributions while its price fell 13.8%. With every distribution reinvested, the fund returned +22.2%. AI and technology (AIQ), used as the AI proxy returned +31.6% over the same days, so a holder was behind by 9.4 pts. At its price on Sep 18, 2026 the latest distribution annualizes to 34.4%, paid weekly. REX estimates that 100% of the distribution paid was a return of capital (19a-1 notice, estimated, a tax characterization rather than a measure of erosion).
BIOY in plain words
Over the period since launch on May 5, 2026 to Sep 18, 2026, BIOY paid 20.6% of its starting value in cash distributions while its price fell 19.0%. With every distribution reinvested, the fund returned +2.0%. Biotech (XBI), used as the proxy returned +17.3% over the same days, so a holder was behind by 15.3 pts. At its price on Sep 18, 2026 the latest distribution annualizes to 60.0%, paid weekly. GraniteShares estimates that 96% of the distribution paid Aug 25, 2026 was a return of capital (19a-1 notice, estimated, a tax characterization rather than a measure of erosion).
Questions people ask
- Which is cheaper, AIPI or BIOY?
- AIPI charges 0.65% a year and BIOY charges 1.07%, so AIPI is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, AIPI against BIOY, data as of Sep 18, 2026. https://etfiq.com/compare/income/aipi-vs-bioy Free to use with attribution; the underlying files are at Open data.